Skip to main content
GutCited

Bacillus coagulans per Irritable Bowel Syndrome (IBS)

B

Reduces abdominal pain, bloating, and diarrhea in IBS. Spore-forming nature provides excellent stability and gastric acid survival.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dbacillus\u002Dcoagulans\u0026condition\u003Dibs'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

In sintesi

Reduces abdominal pain, bloating, and diarrhea in IBS. Spore-forming nature provides excellent stability and gastric acid survival.

Key Study Findings

Meta-Analysis
Strain-Specific Systematic Review with Meta-Analysis of Probiotics Efficacy in the Treatment of Irritable Bowel Syndrome.
Dose: None vs: placebo Outcome: improvement in key IBS symptoms Effetto: None None

Popolazione: patients with IBS from 32 RCTs evaluating 10 probiotic strains

Randomized Controlled Trial n=61 4 weeks Double-blind
Effects of a Bacillus subtilis HU58 and Heyndrickxia faecalis SC208 spore-forming probiotic formula on gastrointestinal …
Dose: None vs: Placebo Outcome: Abdominal pain (NRS) and stool consistency (BSFS) Effetto: None P = 0.003 (pain); P = 0.035 (s

Popolazione: Adults with diarrhoea-predominant IBS (IBS-D)

Randomized Controlled Trial n=100 12 weeks
Role of Bacillus coagulans (Heyndrickxia coagulans)BCP92 in managing irritable bowel syndrome: A randomized, double-blind, multicenter, …
Dose: None vs: Control Outcome: Pain outcomes Effetto: None P < .001

Popolazione: IBS patients

Meta-Analysis
Outcome-Specific Efficacy of Different Probiotic Strains and Mixtures in Irritable Bowel Syndrome: A Systematic Review …
Dose: Various probiotic strains/mixtures vs: Placebo Outcome: Outcome-specific efficacy ranking in IBS Effetto: None None

Popolazione: Adults with IBS (RCTs)

Randomized Controlled Trial 12 weeks Double-blind
The Efficacy and Safety of Single-Strain Probiotic Formulations Containing Bifidobacterium lactis or Bacillus coagulans in …
Dose: 20.5% vs: placebo Outcome: IBS symptom improvement Effetto: None p = 0.038

Popolazione: Adults with IBS

Review
Oral microbial shift induced by probiotic Bacillus coagualans along with its clinical perspectives.
Dose: None vs: None Outcome: colitis/IBD severity Effetto: None None

Popolazione: None

Key Statistics

3

Studi

400

Partecipanti

Positive

B

Grado

Referenced Papers

Beneficial microbes 2019 45 citazioni
Beneficial microbes 2019 29 citazioni

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosaggi di uso comune

general:
1-2 billion CFU/day
ibssupport:
2 billion CFU/day (GBI-30 6086 strain)

Limite massimo: Well-tolerated up to 6 billion CFU/day in clinical trials

Dosaggi studiati nella ricerca

Dosaggio Durata Effetto N
None -- Positive --
None 4 weeks Positive 61
None 12 weeks Positive 100
Various probiotic strains/mixtures -- Positive --
20.5% 12 weeks Positive --
None -- Positive --
None -- Mixed --
None -- Mixed --

Momento migliore per l'assunzione: With meals for optimal spore germination and colonization

Safety & Side Effects

Effetti collaterali segnalati

  • Mild gas during initial use (generally less than other probiotics due to spore form)
  • Occasional bloating
  • Rare loose stools

Interazioni note

  • Antibiotics (spore form is more resistant than vegetative probiotics, but spacing still recommended)
  • Immunosuppressants (theoretical risk in immunocompromised patients)

Livello di assunzione massimo tollerabile: Well-tolerated up to 6 billion CFU/day in clinical trials

Consultare sempre il proprio medico prima di iniziare qualsiasi integratore.Consultate sempre il vostro medico prima di iniziare qualsiasi integratore.

Frequently Asked Questions

Does Bacillus coagulans help with Irritable Bowel Syndrome (IBS)?
Based on 3 studies with 400 participants, there is moderate evidence from clinical studies that Bacillus coagulans may support Irritable Bowel Syndrome (IBS) management. Our evidence grade is B (Good Evidence).
How much Bacillus coagulans should I take for Irritable Bowel Syndrome (IBS)?
Studies have used various dosages. A commonly studied range is 1-2 billion CFU/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Bacillus coagulans?
Reported side effects may include Mild gas during initial use (generally less than other probiotics due to spore form), Occasional bloating, Rare loose stools. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Bacillus coagulans and Irritable Bowel Syndrome (IBS)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 3 peer-reviewed studies with 400 total participants. The overall direction of effect is positive.

Related Evidence

Avvertenza FDA: Queste affermazioni non sono state valutate dalla Food and Drug Administration. I prodotti e le informazioni presenti su questo sito web non sono destinati a diagnosticare, trattare, curare o prevenire alcuna malattia. I gradi di evidenza presentati si basano sulla nostra analisi della ricerca pubblicata e sottoposta a revisione paritaria e non costituiscono consulenza medica. Consultate sempre il vostro medico prima di iniziare qualsiasi regime di integrazione.